Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cyclica and Arctoris expand partnership to progress drug discovery in Alzheimer's disease

March 24, 2022

Discovery of vilazodone-donepezil chimeras for the treatment of AD with comorbid depression

March 24, 2022

Roche discloses new MAGL inhibitors

March 24, 2022

Korean researchers identify new NADPH oxidase inhibitors

March 24, 2022

AC Immune reports images of alpha-synuclein in human brain using new PET tracer

March 23, 2022

New Merck & Co. LRRK2 inhibitors show good drug properties for treating Parkinson's disease

March 23, 2022

IRLAB to advance IRL-757 for apathy in neurodegenerative disorders

March 22, 2022

ASK1 inhibition for the treatment of neuroinflammation, stroke and ALS

March 22, 2022

Grant supports Neuromagen's development of AGS-499 for ALS

March 21, 2022

MagicMed Industries presents 5-HT2A receptor agonists

March 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...